Inpharma Weekly

, Volume 1196, Issue 1, pp 7–7 | Cite as

Dolasetron preferred for PONV prophylaxis

Newsletter Article
  • 3 Downloads

Keywords

Marginal Cost Direct Medical Cost Droperidol Significant Adverse Event Rescue Therapy 

Copyright information

© Adis International Ltd 1999

Personalised recommendations